Filing Details
- Accession Number:
- 0001209191-20-030482
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-19 16:29:44
- Reporting Period:
- 2020-05-15
- Accepted Time:
- 2020-05-19 16:29:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1406338 | Amit Sachdev | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Chief Patient Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-05-15 | 1 | $274.67 | 35,160 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 3 | $276.21 | 35,157 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 1 | $278.42 | 35,156 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 10 | $280.34 | 35,146 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 2 | $281.65 | 35,144 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 5 | $283.01 | 35,139 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 6 | $284.95 | 35,133 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 11 | $286.63 | 35,122 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 13 | $287.65 | 35,109 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 6 | $288.36 | 35,103 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 882 | Indirect | 401(k) |
| Common Stock | 14,002 | Indirect | GRAT |
Footnotes
- Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $276.21 (range $275.87 to $276.44).
- Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $280.34 (range $279.91 to $280.73).
- Open market sales reported on this line occurred at a weighted average price of $281.65 (range $281.24 to $282.06).
- Open market sales reported on this line occurred at a weighted average price of $283.01 (range $282.71 to $283.40).
- Open market sales reported on this line occurred at a weighted average price of $284.95 (range $284.37 to $285.35).
- Open market sales reported on this line occurred at a weighted average price of $286.63 (range $286.14 to $287.12).
- Open market sales reported on this line occurred at a weighted average price of $287.65 (range $287.22 to $288.19).
- Open market sales reported on this line occurred at a weighted average price of $288.36 (range $288.23 to $288.47).
Billionaire Hedge Funds
